Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cardiovascular Endocrinology and Metabolism is Scopus-indexed (Q3, CiteScore 1.7), WoS ESCI, DOAJ. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 2574-0954Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 276 / 409 | 32nd | Q3 |
| Endocrinology, Diabetes and Metabolism | 190 / 250 | 24th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–2025, best quartile Q3, CiteScore 1.7.
Cardiovascular Endocrinology and Metabolism is Q3 in Cardiology and Cardiovascular Medicine (rank 276 of 409) and Q4 in Endocrinology, Diabetes and Metabolism (rank 190 of 250), by CiteScore 2025.
Cardiovascular Endocrinology and Metabolism is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.7, which places it in quartile Q3 at the 32nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.512, quartile Q2, with an H-index of 22.
Cardiovascular Endocrinology and Metabolism is published by Lippincott Williams and Wilkins. Its ISSN is 2574-0954.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Cardiovascular Endocrinology and Metabolism has an h-index of 23 and a 2-year mean of 3.2 citations per paper (OpenAlex). Its Scopus CiteScore is 1.7, quartile Q3. On 2-year citations it ranks #53 of 398 Scopus journals in Cardiology and Cardiovascular Medicine.
Cardiovascular Endocrinology and Metabolism published 22 papers in 2025; its busiest recent year was 2020 with 55. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2021–2026), authors are most often from United States (23%), United Kingdom (10%) and Iran (5.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.